Summers Value Partners on Utah Medical (UTMD): We Believe the Company s Business is Poised to Rebound insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.
Here’s Why Summers Value Partners Exited its Eagle Pharmaceuticals (EGRX) Position
Summers Value Partners, an investment management firm, published its “Summers Value Fund LP” first quarter 2021 investor letter – a copy of which can be downloaded here. A net return of 17.5% was delivered by the fund for the Q1 of 2021, outperforming its e Russell 2000 benchmark that delivered a 12.9% return, but below the Russell Micro-Cap Index that had a 24.0% gain in the same period. You can view the fund’s top 5 holdings to have a peek at their top bets for 2021.
Summers Value Partners, in their Q1 2021 investor letter, mentioned Eagle Pharmaceuticals, Inc. (NASDAQ: EGRX) and shared their insights on the company. Eagle Pharmaceuticals, Inc. is a Woodcliff Lake, New Jersey-based biotechnology company that currently has a $578.2 million market capitalization. Since the beginning of the year, EGRX delivered a -6.06% return, while its 12-month return is also down by -13.07%. As of April 2
Summers Value Partners’ Q1 2021 Investor Letter
Summers Value Partners, an investment management firm, published its “Summers Value Fund LP” first quarter 2021 investor letter – a copy of which can be downloaded here. A net return of 17.5% was delivered by the fund for the Q1 of 2021, outperforming its e Russell 2000 benchmark that delivered a 12.9% return, but below the Russell Micro-Cap Index that had a 24.0% gain in the same period. You can view the fund’s top 5 holdings to have a peek at their top bets for 2021.
Published on April 22, 2021 at 12:12 pm by Inan Dogan, PhD
Warren Buffett never mentions this but he is one of the first hedge fund managers who unlocked the secrets of successful stock market investing. He launched his hedge fund in 1956 with $105,100 in seed capital. Back then they weren’t called hedge funds, they were called “partnerships”. Warren Buffett took 25% of all returns in excess of 6 percent.
Inotiv Inc. (NOTV) Shines Bright in Summers Value Partners’ Q1 2021 Portfolio
Summers Value Partners, an investment management firm, published its “Summers Value Fund LP” first quarter 2021 investor letter – a copy of which can be downloaded here. A net return of 17.5% was delivered by the fund for the Q1 of 2021, outperforming its e Russell 2000 benchmark that delivered a 12.9% return, but below the Russell Micro-Cap Index that had a 24.0% gain in the same period. You can view the fund’s top 5 holdings to have a peek at their top bets for 2021.
Summers Value Partners, in their Q1 2021 investor letter, mentioned Inotiv, Inc. (NASDAQ: NOTV) and shared their insights on the company. Inotiv, Inc. is a West Lafayette, Indiana-based nonclinical and analytical services provider that currently has a $213.9 million market capitalization. Since the beginning of the year, NOTV delivered a 56.26% return, extending its 12-month to 356.53%. As of April 21, 2021, the stock closed at $1
Summers Value Partners’ Q4 2020 Investor Letter
Summers Value Partners, an investment management firm, published its ‘Summers Value Fund LP’ fourth-quarter 2020 Investor Letter – a copy of which can be downloaded here. A net return of 14.7% was recorded by the fund for the Q4 of 2020, below its Russell 2000 benchmark that returned 18.40%. You can view the fund’s top 10 holdings to have a peek at their top bets for 2021.
Published on January 28, 2021 at 11:06 am by Inan Dogan, PhD
Warren Buffett never mentions this but he is one of the first hedge fund managers who unlocked the secrets of successful stock market investing. He launched his hedge fund in 1956 with $105,100 in seed capital. Back then they weren’t called hedge funds, they were called “partnerships”. Warren Buffett took 25% of all returns in excess of 6 percent.